| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |